デフォルト表紙
市場調査レポート
商品コード
1532875

神経科学用抗体・アッセイの世界市場:技術別、用途別、エンドユーザー別、国別、地域別 - 産業分析、市場規模、市場シェア、予測(2024年~2032年)

Neuroscience Antibodies & Assays Market, By Technology, By Application, By End User, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2024-2032


出版日
ページ情報
英文 260 Pages
納期
2~3営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=146.99円
神経科学用抗体・アッセイの世界市場:技術別、用途別、エンドユーザー別、国別、地域別 - 産業分析、市場規模、市場シェア、予測(2024年~2032年)
出版日: 2024年07月30日
発行: AnalystView Market Insights
ページ情報: 英文 260 Pages
納期: 2~3営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

レポートハイライト

世界の神経科学用抗体・アッセイの市場規模は、2023年に42億932万米ドルとなり、2024年~2032年にCAGR10.90%で拡大すると予測されています。

神経科学用抗体・アッセイ市場-市場力学

神経疾患の有病率の増加とバイオテクノロジー産業への投資が市場需要を促進する見込み

アルツハイマー病、パーキンソン病、てんかんなどの神経疾患が拡大しており、これらの疾患に関連するバイオマーカーを正確に検出・研究できるツールの必要性が高まっています。神経科学用抗体・アッセイは、疾患メカニズムに関与する特定のタンパク質、神経伝達物質、その他の分子の同定と定量を可能にすることで、この調査において重要な役割を果たしています。抗体開発、アッセイ技術、イメージング技術の絶え間ない進歩により、神経科学アッセイの感度、特異性、多重化能力は著しく向上しました。これにより、神経疾患に焦点を当てた基礎研究と医薬品開発の両方において、その応用範囲が広がっています。

さらに、バイオテクノロジー企業や製薬企業による神経科学研究への投資が増加し、抗体やアッセイのような信頼性の高いツールへの需要が高まり、市場の成長を後押ししています。これらの企業は、創薬ターゲットの検証、潜在的治療薬のスクリーニング、前臨床試験や臨床試験における治療効果の評価において、堅牢なアッセイに依存しています。したがって、技術的進歩、臨床ニーズ、経済的インセンティブが市場成長を促進すると予想されます。

神経科学用抗体・アッセイ市場-主要インサイト

弊社リサーチアナリストの分析によると、世界市場は予測期間(2024年~2032年)に約10.90%のCAGRで毎年成長すると推定されます。

技術別では、ウェスタンブロッティングやその他の免疫学的疾患の高い流行により、イムノアッセイセグメントが2023年に最大の市場シェアを示すと予測されました。

用途別では、神経科学やバイオテクノロジー用途の研究増加により、創薬・研究開発セグメントが2023年の主要用途でした。

エンドユーザー別では、バイオテクノロジー・製薬企業からの投資の増加により、2023年には製薬・バイオテクノロジー企業セグメントがエンドユーザーのトップでした。

地域別では、臨床診断における神経科学への投資の増加により、北米が2023年の主要収益源でした。

神経科学用抗体・アッセイ市場-セグメント分析:

神経科学用抗体・アッセイの世界市場は、技術、用途、エンドユーザー、地域に基づいてセグメント化されます。

市場は技術別に、イムノアッセイ、分子診断、臨床化学、その他の4つのカテゴリーに分けられます。市場を独占しているのはイムノアッセイセグメントです。ELISAやウェスタンブロッティングタイプの需要が高いことが、同分野の成長に寄与しています。

市場は用途別に創薬・開発、体外診断、研究の3つに分類されます。創薬・開発分野が市場を独占しています。新薬の発見や臨床診断の増加が市場の成長を後押ししています。

市場はエンドユーザー別に製薬・バイオテクノロジー企業、研究機関、病院の3つに分類されます。製薬・バイオテクノロジー企業が市場を独占しており、予測期間中も高い優位性を維持すると予想されます。製薬会社は神経科学と研究に多額の投資を行っており、市場の需要を補完しています。

神経科学用抗体・アッセイ市場-地理的洞察

地理的には、この市場は北米、ラテンアメリカ、欧州、アジア太平洋、中東・アフリカの各地域に広がっています。北米は神経科学用抗体・アッセイ市場の、特に米国で大きなシェアを占めています。この優位性は、大手製薬企業やバイオテクノロジー企業の存在、NIHのような政府機関からの広範な研究資金、確立されたヘルスケアインフラに起因しています。

神経科学用抗体・アッセイ市場-競合情勢:

神経科学用抗体・アッセイ市場の競争は中程度です。神経科学用抗体・アッセイ市場の企業は、製品の性能を高め、研究者の進化するニーズに対応するために絶えず技術革新を行っています。市場参入企業は、戦略的パートナーシップや提携を結び、製品ラインアップや市場参入の拡大を図っています。既存の市場参入企業は、北米、欧州、アジア太平洋などの主要市場における製品の供給とカスタマーサポートを強化するため、流通チャネルに注力しています。

目次

第1章 神経科学用抗体・アッセイ市場概要

  • 調査範囲
  • 市場推定年

第2章 エグゼクティブサマリー

  • 市場内訳
  • 競合考察

第3章 神経科学用抗体・アッセイの主要市場動向

  • 市場促進要因
  • 市場抑制要因
  • 市場機会
  • 市場の将来動向

第4章 神経科学用抗体・アッセイ産業研究

  • PEST分析
  • ポーターのファイブフォース分析
  • 成長見通しマッピング
  • 規制枠組み分析

第5章 神経科学用抗体・アッセイ市場:COVID-19の影響分析

  • COVID-19前の影響分析
  • COVID-19後の影響分析

第6章 神経科学用抗体・アッセイ市場情勢

  • 神経科学用抗体・アッセイ市場シェア分析:2023年
  • 主要メーカー別内訳データ
    • 既存企業の分析
    • 新興企業の分析

第7章 神経科学用抗体・アッセイ市場:技術別

  • 概要
    • 技術別のセグメントシェア分析
    • イノムアッセイ
    • 分子診断
    • 臨床化学
    • その他

第8章 神経科学用抗体・アッセイ市場:用途別

  • 概要
    • 用途別のセグメントシェア分析
    • 創薬・開発
    • 体外診断
    • 研究

第9章 神経科学用抗体・アッセイ市場:エンドユーザー別

  • 概要
    • エンドユーザー別のセグメントシェア分析
    • 製薬・バイオテクノロジー企業
    • 研究機関
    • 病院

第10章 神経科学用抗体・アッセイ市場:地域別

  • イントロダクション
  • 北米
    • 概要
    • 北米の主要メーカー
    • 米国
    • カナダ
  • 欧州
    • 概要
    • 欧州の主要メーカー
    • ドイツ
    • イタリア
    • 英国
    • フランス
    • ロシア
    • オランダ
    • スウェーデン
    • ポーランド
    • その他
  • アジア太平洋(APAC)
    • 概要
    • アジア太平洋の主要メーカー
    • インド
    • 中国
    • 日本
    • 韓国
    • オーストラリア
    • タイ
    • インドネシア
    • フィリピン
    • その他
  • ラテンアメリカ
    • 概要
    • ラテンアメリカの主要メーカー
    • ブラジル
    • メキシコ
    • アルゼンチン
    • コロンビア
    • その他
  • 中東・アフリカ
    • 概要
    • 中東・アフリカの主要メーカー
    • サウジアラビア
    • アラブ首長国連邦
    • イスラエル
    • トルコ
    • アルジェリア
    • エジプト
    • その他

第11章 主要ベンダー分析- 神経科学用抗体・アッセイ業界

  • 競合ダッシュボード
  • 企業プロファイル
    • Thermo Fisher Scientific Inc.
    • Merck KGaA
    • Abcam plc
    • Bio-Rad Laboratories
    • Cell Signaling Technology
    • MilliporeSigma
    • Agilent Technologies
    • BioLegend
    • Santa Cruz Biotechnology
    • OriGene Technologies
    • GenScript
    • R&D Systems
    • Novus Biologicals
    • RayBiotech
    • Rockland Immunochemicals
    • Others

第12章 アナリストの全方位展望

図表

List of Tables

  • TABLE List of data sources
  • TABLE Market drivers; Impact Analysis
  • TABLE Market restraints; Impact Analysis
  • TABLE Neuroscience Antibodies & Assays Market: Technology Snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by Technology
  • TABLE Global Neuroscience Antibodies & Assays Market, by Technology 2019-2032 (USD Million)
  • TABLE Neuroscience Antibodies & Assays Market: Application Snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by Application
  • TABLE Global Neuroscience Antibodies & Assays Market, by Application 2019-2032 (USD Million)
  • TABLE Neuroscience Antibodies & Assays Market: End User Snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by End User
  • TABLE Global Neuroscience Antibodies & Assays Market, by End User 2019-2032 (USD Million)
  • TABLE Neuroscience Antibodies & Assays Market: Regional snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by Region
  • TABLE Global Neuroscience Antibodies & Assays Market, by Region 2019-2032 (USD Million)
  • TABLE North America Neuroscience Antibodies & Assays Market, by Country, 2019-2032 (USD Million)
  • TABLE North America Neuroscience Antibodies & Assays Market, by Technology, 2019-2032 (USD Million)
  • TABLE North America Neuroscience Antibodies & Assays Market, by Application, 2019-2032 (USD Million)
  • TABLE North America Neuroscience Antibodies & Assays Market, by End User, 2019-2032 (USD Million)
  • TABLE Europe Neuroscience Antibodies & Assays Market, by Country, 2019-2032 (USD Million)
  • TABLE Europe Neuroscience Antibodies & Assays Market, by Technology, 2019-2032 (USD Million)
  • TABLE Europe Neuroscience Antibodies & Assays Market, by Application, 2019-2032 (USD Million)
  • TABLE Europe Neuroscience Antibodies & Assays Market, by End User, 2019-2032 (USD Million)
  • TABLE Asia Pacific Neuroscience Antibodies & Assays Market, by Country, 2019-2032 (USD Million)
  • TABLE Asia Pacific Neuroscience Antibodies & Assays Market, by Technology, 2019-2032 (USD Million)
  • TABLE Asia Pacific Neuroscience Antibodies & Assays Market, by Application, 2019-2032 (USD Million)
  • TABLE Asia Pacific Neuroscience Antibodies & Assays Market, by End User, 2019-2032 (USD Million)
  • TABLE Latin America Neuroscience Antibodies & Assays Market, by Country, 2019-2032 (USD Million)
  • TABLE Latin America Neuroscience Antibodies & Assays Market, by Technology, 2019-2032 (USD Million)
  • TABLE Latin America Neuroscience Antibodies & Assays Market, by Application, 2019-2032 (USD Million)
  • TABLE Latin America Neuroscience Antibodies & Assays Market, by End User, 2019-2032 (USD Million)
  • TABLE Middle East and Africa Neuroscience Antibodies & Assays Market, by Country, 2019-2032 (USD Million)
  • TABLE Middle East and Africa Neuroscience Antibodies & Assays Market, by Technology, 2019-2032 (USD Million)
  • TABLE Middle East and Africa Neuroscience Antibodies & Assays Market, by Application, 2019-2032 (USD Million)
  • TABLE Middle East and Africa Neuroscience Antibodies & Assays Market, by End User, 2019-2032 (USD Million)

List of Figures

  • FIGURE Neuroscience Antibodies & Assays Market Segmentation
  • FIGURE Market research methodology
  • FIGURE Value chain analysis
  • FIGURE Porter's Five Forces Analysis
  • FIGURE Market Attractiveness Analysis
  • FIGURE COVID-19 Impact Analysis
  • FIGURE Pre & Post COVID-19 Impact Comparision Study
  • FIGURE Competitive Landscape; Key company market share analysis, 2023
  • FIGURE Technology segment market share analysis, 2023 & 2032
  • FIGURE Technology segment market size forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Application segment market share analysis, 2023 & 2032
  • FIGURE Application segment market size forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE End User segment market share analysis, 2023 & 2032
  • FIGURE End User segment market size forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Regional segment market share analysis, 2023 & 2032
  • FIGURE Regional segment market size forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE North America Neuroscience Antibodies & Assays Market share and leading players, 2023
  • FIGURE Europe Neuroscience Antibodies & Assays Market share and leading players, 2023
  • FIGURE Asia Pacific Neuroscience Antibodies & Assays Market share and leading players, 2023
  • FIGURE Latin America Neuroscience Antibodies & Assays Market share and leading players, 2023
  • FIGURE Middle East and Africa Neuroscience Antibodies & Assays Market share and leading players, 2023
  • FIGURE North America market share analysis by country, 2023
  • FIGURE U.S. Neuroscience Antibodies & Assays Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Canada Neuroscience Antibodies & Assays Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Europe Neuroscience Antibodies & Assays Market share analysis by country, 2023
  • FIGURE Germany Neuroscience Antibodies & Assays Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Spain Neuroscience Antibodies & Assays Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Italy Neuroscience Antibodies & Assays Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE France Neuroscience Antibodies & Assays Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE UK Neuroscience Antibodies & Assays Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Russia Neuroscience Antibodies & Assays Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Netherlands Neuroscience Antibodies & Assays Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Sweden Neuroscience Antibodies & Assays Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Poland Neuroscience Antibodies & Assays Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Rest of the Europe Neuroscience Antibodies & Assays Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Asia Pacific Neuroscience Antibodies & Assays Market share analysis by country, 2023
  • FIGURE India Neuroscience Antibodies & Assays Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE China Neuroscience Antibodies & Assays Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Japan Neuroscience Antibodies & Assays Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE South Korea Neuroscience Antibodies & Assays Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Australia Neuroscience Antibodies & Assays Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Thailand Neuroscience Antibodies & Assays Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Indonesia Neuroscience Antibodies & Assays Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Philippines Neuroscience Antibodies & Assays Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Rest of APAC Neuroscience Antibodies & Assays Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Latin America Neuroscience Antibodies & Assays Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Latin America Neuroscience Antibodies & Assays Market share analysis by country, 2023
  • FIGURE Brazil Neuroscience Antibodies & Assays Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Mexico Neuroscience Antibodies & Assays Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Argentina Neuroscience Antibodies & Assays Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Colombia Neuroscience Antibodies & Assays Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Rest of LATAM Neuroscience Antibodies & Assays Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Middle East and Africa Neuroscience Antibodies & Assays Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Middle East and Africa Neuroscience Antibodies & Assays Market share analysis by country, 2023
  • FIGURE Saudi Arabia Neuroscience Antibodies & Assays Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE United Arab Emirates Neuroscience Antibodies & Assays Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Israel Neuroscience Antibodies & Assays Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Turkey Neuroscience Antibodies & Assays Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Algeria Neuroscience Antibodies & Assays Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Egypt Neuroscience Antibodies & Assays Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Rest of MEA Neuroscience Antibodies & Assays Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
目次
Product Code: ANV3494

REPORT HIGHLIGHT

Neuroscience Antibodies & Assays Market size was valued at USD 4,209.32 Million in 2023, expanding at a CAGR of 10.90% from 2024 to 2032.

Neuroscience antibodies and assays are kind of tools and techniques used in neuroscience research to study the nervous system at the molecular level. Neuroscience antibodies and assays play a crucial role in advancing our understanding of brain structure and function, aiding research into neurodevelopmental disorders, neurodegenerative diseases, and synaptic plasticity.

Neuroscience Antibodies & Assays Market- Market Dynamics

The growing prevalence of neurological disorders and investment in biotech industries are expected to fuel market demand

Neurological disorders such as Alzheimer's disease, Parkinson's disease, epilepsy, and others expand, and there is a growing need for tools that can accurately detect, and study biomarkers associated with these conditions. Neuroscience antibodies and assays play a crucial role in this research by enabling the identification and quantification of specific proteins, neurotransmitters, and other molecules implicated in disease mechanisms. Continuous advancements in antibody development, assay techniques, and imaging technologies have significantly enhanced the sensitivity, specificity, and multiplexing capabilities of neuroscience assays. This has broadened their application in both basic research and drug development efforts focused on neurological disorders.

Furthermore, increased investment from biotechnology and pharmaceutical companies into neuroscience research drives the demand for reliable tools like antibodies and assays, boosting the market growth. These companies rely on robust assays to validate drug targets, screen potential therapeutics, and assess treatment efficacy in preclinical and clinical studies. Thus, technological advancements, clinical needs, and economic incentives are expected to foster market growth.

Neuroscience Antibodies & Assays Market- Key Insights

As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 10.90% over the forecast period (2024-2032)

Based on Technology segmentation, the immunoassays segment was predicted to show maximum market share in the year 2023, owing to its high prevalence of western blotting, and other immunology diseases.

Based on Application segmentation, the drug discovery & development segment was the leading Application in 2023, due to increased research in neuroscience and biotech applications.

Based on End User segmentation, pharmaceutical & biotech companies' segment was the leading End User in 2023, owing to increased investment from biotechnology and pharmaceutical companies.

On the basis of region, North America was the leading revenue generator in 2023, owing to higher investment in neuroscience in clinical diagnostics.

Neuroscience Antibodies & Assays Market- Segmentation Analysis:

The Global Neuroscience Antibodies & Assays Market is segmented on the basis of Technology, Application, End User, and Region.

The market is divided into four categories based on Technology: immunoassays, molecular diagnostics, clinical chemistry, and others. The immunoassays segment dominates the market. The high demand from ELISA, and western blotting types are contributing to segment growth.

The market is divided into three categories based on Application: drug discovery & development, in-vitro diagnostics, and research. The drug discovery & development segment dominates the market. The increasing number of novel drug discoveries and clinical diagnostics are fueling market growth.

The market is divided into three categories based on End Users: pharmaceutical & biotech companies, research institutes, and hospitals. The pharmaceutical & biotech companies segment dominates the market and is expected to maintain its high dominance during the forecast period. Pharmaceutical companies are investing heavily in neuroscience and research supplementing market demand.

Neuroscience Antibodies & Assays Market- Geographical Insights

Geographically, this market is widespread in the regions of North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. North America holds a substantial share of the neuroscience antibodies and assays market, particularly the United States. This dominance is attributed to the presence of major pharmaceutical and biotechnology companies, extensive research funding from government agencies like NIH, and a well-established healthcare infrastructure.

Neuroscience Antibodies & Assays Market- Competitive Landscape:

The Neuroscience Antibodies & Assays market is moderately competitive in nature. Companies in the neuroscience antibodies and assays market continually innovate to enhance product performance and meet the evolving needs of researchers. Market players engage in strategic partnerships and collaborations to expand their product offerings and market reach. Existing market players focus on distribution channels to enhance product availability and customer support in key markets such as North America, Europe, and Asia-Pacific.

Recent Developments:

In September 2022, NIH has launched two transformative projects supported by BRAIN research initiative.

In July 2022, Pasithea Therapeutics got funding of USD 1.3 million for research in anti-integrin antibodies.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL NEUROSCIENCE ANTIBODIES & ASSAYS MARKET KEY PLAYERS

  • Thermo Fisher Scientific
  • Merck KGaA
  • Abcam plc
  • Bio-Rad Laboratories
  • Cell Signaling Technology
  • MilliporeSigma
  • Agilent Technologies
  • BioLegend
  • Santa Cruz Biotechnology
  • OriGene Technologies
  • GenScript
  • R&D Systems
  • Novus Biologicals
  • RayBiotech
  • Rockland Immunochemicals
  • Others

GLOBAL NEUROSCIENCE ANTIBODIES & ASSAYS MARKET, BY TECHNOLOGY- MARKET ANALYSIS, 2019-2032

  • Immunoassays
  • Molecular diagnostics
  • Clinical chemistry
  • Others

GLOBAL NEUROSCIENCE ANTIBODIES & ASSAYS MARKET, BY APPLICATION- MARKET ANALYSIS, 2019-2032

  • Drug discovery & development
  • In-vitro diagnostics
  • Research

GLOBAL NEUROSCIENCE ANTIBODIES & ASSAYS MARKET, BY END USER- MARKET ANALYSIS, 2019-2032

  • Pharmaceutical & biotech companies
  • Research institutes
  • Hospitals

GLOBAL NEUROSCIENCE ANTIBODIES & ASSAYS MARKET, BY REGION- MARKET ANALYSIS, 2019-2032

  • North America
  • The U.S.
  • Canada
  • Europe
  • Germany
  • France
  • Italy
  • Spain
  • United Kingdom
  • Russia
  • Netherlands
  • Sweden
  • Poland
  • Rest of Europe
  • Asia Pacific
  • India
  • China
  • South Korea
  • Japan
  • Australia
  • Thailand
  • Indonesia
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • United Arab Emirates
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1. Neuroscience Antibodies & Assays Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Neuroscience Antibodies & Assays Market Snippet by Technology
    • 2.1.2. Neuroscience Antibodies & Assays Market Snippet by Application
    • 2.1.3. Neuroscience Antibodies & Assays Market Snippet by End User
    • 2.1.4. Neuroscience Antibodies & Assays Market Snippet by Country
    • 2.1.5. Neuroscience Antibodies & Assays Market Snippet by Region
  • 2.2. Competitive Insights

3. Neuroscience Antibodies & Assays Key Market Trends

  • 3.1. Neuroscience Antibodies & Assays Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Neuroscience Antibodies & Assays Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Neuroscience Antibodies & Assays Market Opportunities
  • 3.4. Neuroscience Antibodies & Assays Market Future Trends

4. Neuroscience Antibodies & Assays Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Neuroscience Antibodies & Assays Market: COVID-19 Impact Analysis

  • 5.1. Pre-COVID-19 Impact Analysis
  • 5.2. Post-COVID-19 Impact Analysis
    • 5.2.1. Top Performing Segments
    • 5.2.2. Marginal Growth Segments
    • 5.2.3. Top Looser Segments
    • 5.2.4. Marginal Loss Segments

6. Neuroscience Antibodies & Assays Market Landscape

  • 6.1. Neuroscience Antibodies & Assays Market Share Analysis, 2023
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Neuroscience Antibodies & Assays Market - By Technology

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Technology, 2024 & 2032 (%)
    • 7.1.2. Immunoassays
    • 7.1.3. Molecular diagnostics
    • 7.1.4. Clinical chemistry
    • 7.1.5. Others

8. Neuroscience Antibodies & Assays Market - By Application

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Application, 2024 & 2032 (%)
    • 8.1.2. Drug discovery & development
    • 8.1.3. In-vitro diagnostics
    • 8.1.4. Research

9. Neuroscience Antibodies & Assays Market - By End User

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By End User, 2024 & 2032 (%)
    • 9.1.2. Pharmaceutical & biotech companies
    • 9.1.3. Research institutes
    • 9.1.4. Hospitals

10. Neuroscience Antibodies & Assays Market- By Geography

  • 10.1. Introduction
    • 10.1.1. Segment Share Analysis, By Geography, 2024 & 2032 (%)
  • 10.2. North America
    • 10.2.1. Overview
    • 10.2.2. Neuroscience Antibodies & Assays Key Manufacturers in North America
    • 10.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.2.4. North America Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 10.2.5. North America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.2.6. North America Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.2.7. U.S.
      • 10.2.7.1. Overview
      • 10.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.2.7.3. U.S. Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.2.7.4. U.S. Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.2.7.5. U.S. Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.2.8. Canada
      • 10.2.8.1. Overview
      • 10.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.2.8.3. Canada Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.2.8.4. Canada Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.2.8.5. Canada Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 10.3. Europe
    • 10.3.1. Overview
    • 10.3.2. Neuroscience Antibodies & Assays Key Manufacturers in Europe
    • 10.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.3.4. Europe Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 10.3.5. Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.3.6. Europe Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.7. Germany
      • 10.3.7.1. Overview
      • 10.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.7.3. Germany Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.3.7.4. Germany Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.7.5. Germany Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.8. Italy
      • 10.3.8.1. Overview
      • 10.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.8.3. Italy Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.3.8.4. Italy Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.8.5. Italy Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.9. United Kingdom
      • 10.3.9.1. Overview
      • 10.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.9.3. United Kingdom Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.3.9.4. United Kingdom Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.9.5. United Kingdom Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.10. France
      • 10.3.10.1. Overview
      • 10.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.10.3. France Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.3.10.4. France Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.10.5. France Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.11. Russia
      • 10.3.11.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.11.2. Russia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.3.11.3. Russia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.11.4. Russia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.12. Netherlands
      • 10.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.12.2. Netherlands Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.3.12.3. Netherlands Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.12.4. Netherlands Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.13. Sweden
      • 10.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.13.2. Sweden Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.3.13.3. Sweden Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.13.4. Sweden Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.14. Poland
      • 10.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.14.2. Poland Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.3.14.3. Poland Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.14.4. Poland Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.15. Rest of Europe
      • 10.3.15.1. Overview
      • 10.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.15.3. Rest of the Europe Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.3.15.4. Rest of the Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.15.5. Rest of the Europe Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 10.4. Asia Pacific (APAC)
    • 10.4.1. Overview
    • 10.4.2. Neuroscience Antibodies & Assays Key Manufacturers in Asia Pacific
    • 10.4.3. Asia Pacific Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.4.4. Asia Pacific Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 10.4.5. Asia Pacific Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.4.6. Asia Pacific Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.7. India
      • 10.4.7.1. Overview
      • 10.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.7.3. India Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.4.7.4. India Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.7.5. India Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.8. China
      • 10.4.8.1. Overview
      • 10.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.8.3. China Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.4.8.4. China Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.8.5. China Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.9. Japan
      • 10.4.9.1. Overview
      • 10.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.9.3. Japan Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.4.9.4. Japan Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.9.5. Japan Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.10. South Korea
      • 10.4.10.1. Overview
      • 10.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.10.3. South Korea Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.4.10.4. South Korea Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.10.5. South Korea Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.11. Australia
      • 10.4.11.1. Overview
      • 10.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.11.3. Australia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.4.11.4. Australia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.11.5. Australia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.12. Thailand
      • 10.4.12.1. Overview
      • 10.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.12.3. Thailand Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.4.12.4. Thailand Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.12.5. Thailand Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.13. Indonesia
      • 10.4.13.1. Overview
      • 10.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.13.3. Indonesia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.4.13.4. Indonesia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.13.5. Indonesia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.14. Philippines
      • 10.4.14.1. Overview
      • 10.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.14.3. Philippines Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.4.14.4. Philippines Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.14.5. Philippines Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.15. Rest of APAC
      • 10.4.15.1. Overview
      • 10.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.15.3. Rest of APAC Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.4.15.4. Rest of APAC Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.15.5. Rest of APAC Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 10.5. Latin America
    • 10.5.1. Overview
    • 10.5.2. Neuroscience Antibodies & Assays Key Manufacturers in Latin America
    • 10.5.3. Latin America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.5.4. Latin America Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 10.5.5. Latin America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.5.6. Latin America Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.5.7. Brazil
      • 10.5.7.1. Overview
      • 10.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.7.3. Brazil Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.5.7.4. Brazil Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.5.7.5. Brazil Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.5.8. Mexico
      • 10.5.8.1. Overview
      • 10.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.8.3. Mexico Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.5.8.4. Mexico Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.5.8.5. Mexico Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.5.9. Argentina
      • 10.5.9.1. Overview
      • 10.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.9.3. Argentina Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.5.9.4. Argentina Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.5.9.5. Argentina Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.5.10. Colombia
      • 10.5.10.1. Overview
      • 10.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.10.3. Colombia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.5.10.4. Colombia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.5.10.5. Colombia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.5.11. Rest of LATAM
      • 10.5.11.1. Overview
      • 10.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.11.3. Rest of LATAM Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.5.11.4. Rest of LATAM Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.5.11.5. Rest of LATAM Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 10.6. Middle East and Africa
    • 10.6.1. Overview
    • 10.6.2. Neuroscience Antibodies & Assays Key Manufacturers in Middle East and Africa
    • 10.6.3. Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.6.4. Middle East and Africa Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 10.6.5. Middle East and Africa Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.6.6. Middle East and Africa Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.6.7. Saudi Arabia
      • 10.6.7.1. Overview
      • 10.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.7.3. Saudi Arabia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.6.7.4. Saudi Arabia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.7.5. Saudi Arabia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.6.8. United Arab Emirates
      • 10.6.8.1. Overview
      • 10.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.8.3. United Arab Emirates Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.6.8.4. United Arab Emirates Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.8.5. United Arab Emirates Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.6.9. Israel
      • 10.6.9.1. Overview
      • 10.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.9.3. Israel Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.6.9.4. Israel Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.9.5. Israel Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.6.10. Turkey
      • 10.6.10.1. Overview
      • 10.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.10.3. Turkey Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.6.10.4. Turkey Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.10.5. Turkey Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.6.11. Algeria
      • 10.6.11.1. Overview
      • 10.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.11.3. Algeria Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.6.11.4. Algeria Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.11.5. Algeria Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.6.12. Egypt
      • 10.6.12.1. Overview
      • 10.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.12.3. Egypt Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.6.12.4. Egypt Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.12.5. Egypt Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.6.13. Rest of MEA
      • 10.6.13.1. Overview
      • 10.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.13.3. Rest of MEA Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.6.13.4. Rest of MEA Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.13.5. Rest of MEA Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)

11. Key Vendor Analysis- Neuroscience Antibodies & Assays Industry

  • 11.1. Competitive Dashboard
  • 11.2. Company Profiles
    • 11.2.1. Thermo Fisher Scientific Inc.
    • 11.2.2. Merck KGaA
    • 11.2.3. Abcam plc
    • 11.2.4. Bio-Rad Laboratories
    • 11.2.5. Cell Signaling Technology
    • 11.2.6. MilliporeSigma
    • 11.2.7. Agilent Technologies
    • 11.2.8. BioLegend
    • 11.2.9. Santa Cruz Biotechnology
    • 11.2.10. OriGene Technologies
    • 11.2.11. GenScript
    • 11.2.12. R&D Systems
    • 11.2.13. Novus Biologicals
    • 11.2.14. RayBiotech
    • 11.2.15. Rockland Immunochemicals
    • 11.2.16. Others

12. 360 Degree Analyst View

13. Appendix

  • 13.1. Research Methodology
  • 13.2. References
  • 13.3. Abbreviations
  • 13.4. Disclaimer
  • 13.5. Contact Us